Predictive Factors and Outcome in Medical Thoracoscopy

Retrospective survey for factors predicting the outcome of medical thoracoscopy

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pleuritis Infections Pleural Diseases Pleurisy Respiratory Tract Diseases Respiratory Tract Infections

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

UZ Leuven

Leuven, 3000, Belgium

About this study

Retrospective survey for factors predicting the outcome of medical thoracoscopy in patients with malignant pleuritis

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

progressive malignancy
pleuritis

Exclusion criteria

respiratory failure
unable to consent

Treatment and study plan

sterile talc pleurodesis

Drug

medical thoracoscopy and talc pleurodesis. No specific device is studied.

Other names: medical thoracoscopy

Primary outcomes

Chest X-ray

Time frame: 3 months

radiological resolution of pleuritis; 3 level severity grading (A, B, C, with C as worst grade)

Secondary outcomes

time interval

Time frame: 12 months

survival in months

Sponsors and collaborators

Lead sponsor

KU Leuven

Other

Registry information

Important dates

Study start: 2014
Primary completion: 2016
Study completion: 2016
First posted: Nov 11, 2014
Registry last updated: Dec 30, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed